April 2019 : Endress+Hauser India process automation major has steadily evolved from a sensor maker for process automation into a major supplier of complete automation solutions and is eyeing growth in domestic sales in India.
Endress+Hauser total revenue from India is around 1,100 crores. Domestic sales account for nearly 30 % (nearly 300 crore) while the remaining (nearly 1,000 crore) comes from exports to South East Asian countries, South Africa and Australia. Domestic sales are estimated to grow to Rs. 800 Crore by 2020-21.
Endress+Hauser India eyes growth in domestic sales
Kailash Desai, CEO, Endress+Hauser India says, “We offer comprehensive process solutions for measurement of flow, level, pressure, analysis, temperature, including registration and digital communications, across a wide range of industries. Our offerings optimise process efficiency, provide safe operations and help protect the environment.”
India is a hub of Internet of Things ( IoT) falling next to the US when it comes to market share and ventures running IoT businesses. Endress+Hauser company is still evolving and bringing in newer changes for which it requires skilled IoT professionals. The company is a global leader in measurement instrumentation, services and solutions for industrial process engineering.
Endress+Hauser aims to tap opportunities for industries and cater to the increasing demands for innovations and technological advancements which aim to modernise the industrial applications. Smart technology is a major driver in the next stage of industry 4.0. With the drastic rise in number of smart factories and digitalization, intelligent products will become a key factor for economic success. Endress+Hauser innovative product comes into play, making an important contribution to the continuous process verification and quality control during production that we are aiming for 4.0. Such solutions find use in industries like water and waste water management, food and beverages, life sciences, chemical and oil & gas, among others”.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022
